摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methylthio-4,5,6,7-tetrahydro-1H-1,3-diazepine hydroiodide | 3358-42-7

中文名称
——
中文别名
——
英文名称
2-methylthio-4,5,6,7-tetrahydro-1H-1,3-diazepine hydroiodide
英文别名
4,5,6,7-tetrahydro-2-(methylthio)-1H-1,3-diazepine hydriodide;2-methylthio-1,3-diaza-1-cycloheptenethiuronium iodide;2-methylsulfanyl-4,5,6,7-tetrahydro-1H-[1,3]diazepine; hydriodide;2-Methylmercapto-4,5,6,7-tetrahydro-1H-[1,3]diazepin; Hydrojodid;4,5,6,7-tetrahydro-2-(methylthio)-1H-1,3-diazepine, hydroiodide;2-methylthio-1,4,5,6,7-pentahydro-1,3-diazepine hydroiodide;hydron;2-methylsulfanyl-4,5,6,7-tetrahydro-1H-1,3-diazepine;iodide
2-methylthio-4,5,6,7-tetrahydro-1H-1,3-diazepine hydroiodide化学式
CAS
3358-42-7
化学式
C6H12N2S*HI
mdl
——
分子量
272.153
InChiKey
ZXRLJUNOKBUKHA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.71
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-methylthio-4,5,6,7-tetrahydro-1H-1,3-diazepine hydroiodide 生成 nitric acid;4,5,6,7-tetrahydro-1H-1,3-diazepin-2-amine
    参考文献:
    名称:
    RASMUSSEN, C. R.
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Strong reducing agents containing dimolybdenum Mo24+ units and their oxidized cations with Mo25+/6+ cores stabilized by bicyclic guanidinate anions with a seven-membered ring
    摘要:
    报告了两种含有两个稠环的二环胍基配体hpp(hpp = 胍基化合物1,3,4,6,7,8-六氢-2H-嘧啶并[1,2a]嘧啶的阴离子)类似物的合成。每种化合物包含一个七元环,而另一个要么是五元环(Htbd),要么是六元环(Htbu)。在THF/Bu4NPF6中,二钼化合物Mo2(tbd)4和Mo2(tbu)4很容易被氧化,它们在差分脉冲伏安图中的信号分别为-1.059和-1.009 V(相对于Ag/AgCl),对于Mo25+/6+偶合,信号顺序为-0.242和-0.312 V,对于Mo26+/5+偶合,信号顺序为-0.242和-0.312 V。这两种化合物在溶于CH2Cl2后立即产生相应的Mo2(二环胍基)4Cl化合物,这些化合物很容易形成具有Mo26+核心的物种。在Mo2(tbd)4Cl中,有两个晶体学上独立的分子,Mo-Mo距离分别为2.1711(7)和2.
    DOI:
    10.1039/b608422b
点击查看最新优质反应信息

文献信息

  • [EN] TETRAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONITS<br/>[FR] COMPOSES DE TETRAZOLE ET LEUR UTILISATION COMME ANTAGONISTES DE RECEPTEURS DE GLUTAMATE METABOTROPIQUES
    申请人:ASTRAZENECA AB
    公开号:WO2005080356A1
    公开(公告)日:2005-09-01
    The present invention relates to new compounds of formula I, wherein P, Q, X1, X2, X3, X4, R1, R2, m and p, are as defined as in formula I, or salts, solvates or solvated salts thereof, processes for their preparation and new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds, and to the use of said compounds in therapy.
    本发明涉及公式I的新化合物,其中P、Q、X1、X2、X3、X4、R1、R2、m和p如公式I中所定义,或其盐、溶剂合物或溶剂化盐,其制备方法及用于制备所述化合物的新中间体,含有所述化合物的药物组合物,以及所述化合物在治疗中的使用。
  • MGluR5 modulators V
    申请人:Wallberg Andreas
    公开号:US20070259860A1
    公开(公告)日:2007-11-08
    The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
    本发明涉及新化合物,以及用于它们制备的方法,它们在治疗中的应用以及包含这些新化合物的药物组合物。
  • Platinum chelates of 2-hydrazino-azoles
    申请人:American Cyanamid Company
    公开号:US04550169A1
    公开(公告)日:1985-10-29
    This disclosure describes platinum chelates of 2-hydrazino-1-aza (or 1,3-diaza,1-oxa-3-aza or 1-thia-3-aza)-1-cyclo-alkenes which possess activity as antitumor agents.
    本公开涉及具有抗肿瘤活性的2-叠氮基-1-氮杂环烯的螯合物(或1,3-二氮杂、1-氧-3-氮杂或1--3-氮杂)。
  • PREPARATION AND CHEMISTRY OF Δ<sup>8</sup>-HEXAHYDRO-1,4,8-PYRIMIDAZOLE, Δ<sup>9</sup>-1,5,9-TRIAZABICYCLO(4.4.0)DECENE, AND Δ<sup>9</sup>-1,4,9-TRIAZABICYGLO(5.3.0)DECENE
    作者:A. F. Mckay、M.-E. Kreling
    DOI:10.1139/v57-190
    日期:1957.12.1

    The preparations of Δ8-hexahydro-1,4,8-pyrimidazole, Δ9-1,5,9-triazabicyclo(4.4.0)decene, and Δ9-1,4,9-triazabicyclo(5.3.0)decene from the corresponding 2-(ω-hydroxyalkylamino)-Δ2-1,3-diazacycloalkenes by chlorination and dehydrohalogenation are described. The nitro derivatives of these bicyclic compounds are more stable towards refluxing ethanol than 1-nitro-2,3,5,6-tetrahydro-1-imidaz(1,2-a)imidazole.

    Δ8-六氢-1,4,8-嘧啶,Δ9-1,5,9-三氮杂双环(4.4.0)癸烯和Δ9-1,4,9-三氮杂双环(5.3.0)癸烯的制备方法从相应的2-(ω-羟基烷基基)-Δ2-1,3-二氮杂环烯经化和脱卤反应得到。这些双环化合物的硝基衍生物在回流乙醇中比1-硝基-2,3,5,6-四氢-1-咪唑(1,2-a)咪唑稳定。
  • 2-(1,3-Diazacycloalkenyl)-2-hydrazones of substituted chalcones
    申请人:American Cyanamid Company
    公开号:US03931152A1
    公开(公告)日:1976-01-06
    The preparation of 2-(1,3-Diazacycloalkenyl)-2-hydrazones of substituted chalcones is described. These compounds are useful as anti-tubercular agents in warm-blooded animals.
    描述了取代香豆素的2-(1,3-二氮杂环烯基)-2-酮的制备。这些化合物在温血动物中作为抗结核药物是有用的。
查看更多

同类化合物

雷唑巴占 唑美巴占 六氢-2-(硝基亚氨基)-1H-1,3-二氮杂卓 [1,3]恶唑并[3,2-a][1,3]二氮杂卓 7-苯基-3,4-二氢-1H-1,4-二氮杂革-5(2H)-酮 7,8-二氢-1-苯基-6H-吡啶并(3,2,1-jk)(1,4)苯并二氮杂卓-4(3H)-酮 5H-吡咯并[1,2-a][1,4]二氮杂卓 5-甲基-7-苯基-6,7-二氢-1H-1,4-二氮杂-2,3-二甲腈 5-三氟甲基-2,3-二氢-1H-1,4-二氮杂卓 5,7-二苯基-2,3,6,7-四氢-1H-1,4-二氮杂卓 5,7-二甲基-2,3-二氢-1H-[1,4]二氮杂卓高氯酸盐 5,7-二甲基-2,3,5,6-四氢-1H-环戊二烯并[b]吡嗪 4,5,6,7-四氢-1H-1,3-二氮杂卓-2-胺 3,5,7-三苯基-4H-1,2-二氮杂卓 2H-[1,3,5]恶二嗪o[3,2-a][1,3]二氮杂卓 2-甲基硫代-4,5,6,7-四氢-1H-[1,3]二氮杂卓 2-甲基-4,5,6,7-四氢-1H-1,3-二氮杂卓 2,3-二氢-5-甲基-7-三氟甲基-1H-1,4-二氮杂卓 2,3-二氢-5,7-双(三氟甲基)-1H-1,4-二氮杂卓 1-(5-甲氧基-1,4-二氮杂-1-基)乙酮 1,4,5,7,8,9,10,10A-八氢吡啶并[1,2-a][1,4]二氮杂卓 (9ci)-2,3-二氢-N,N-二甲基-1H-1,4-二氮杂卓-6-甲胺 (9ci)-1H-1,2-二氮杂卓-1-羧酸甲酯 (9ci)-1H,3h-噁唑并[3,4-d][1,4]二氮杂卓 (9ci)-1H,3h-噁唑并[3,4-a][1,4]二氮杂卓 8-Phenyl-2,3,6,7-tetrahydro-4H-1,4-diazocin-5-on 1,3-diphenyl-1,2-dihydro-pyridazino[3,4-b]quinoxaline 3-(4-Bromphenyl)-5,6,7,8-tetrahydro-thiazolo<3,2-a>-<1,3>diazepin 2,3-Dihydro-5-methyl-1,4-diazepin 3-Methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine 2,4,10,12,18,20-hexamethyl-1,5,9,13,17,21-hexaaza-cyclotetracosa-1,3,9,11,17,19-hexaene 2-(2-benzylidene-3-((4-methylbenzylidene)hydrazineylidene)-2,3,6,7,8,9-hexahydro-5H-thiazolo[2,3-b]quinazolin-5-yl)phenol 3,11-diphenyl-1,5,9,13-tetraaza-cyclohexadeca-1,3,9,11-tetraene 7,10-dichloro-4-[4-(1,1-difluoroethyl)phenyl]-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]-benzodiazepine hydrochloride 7-bromo-5,6-dihydro-2,3-dimethylpyrido<2,3-b>pyrazine 7-(3-Chloro-4-fluoro-phenyl)-5-trifluoromethyl-2,3-dihydro-1H-[1,4]diazepine 6,14-diphenyl-1,4,8,12-tetraaza-cyclopentadeca-4,6,12,14-tetraene 6,13-diphenyl-1,4,8,11-tetraaza-cyclotetradeca-4,6,11,13-tetraene 7-(3-Chloro-4-fluoro-phenyl)-5-phenyl-2,3-dihydro-1H-[1,4]diazepine 7-(4-Fluoro-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine 3-(7-methyl-5-oxo-4,5-dihydro-2H-pyrazolo[1,5-a]pyrimidin-1-yl)-but-2-enenitrile 7-(2-Fluoro-5-methyl-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine trans-diazido(2,3,9,10-tetramethyl-1,4,8,11-tetra-azacyclotetradeca-1,3,8,10-tetraene)cobalt(III) perchlorate 2,2-dimethyl-2,6,7,8-tetrahydro-3H-pyrrolo[1,2-a]pyrimidin-4-one ethyl 4-acetamidodiazepine-1-carboxylate 5,7-dimethyl-4,5,6,7-tetrahydro-1H-[1,4]diazepine-2,3-dicarbonitrile 1,4,8,11-Tetraazacyclotetradeca-4,6,11,13-tetraene,5,7,12,14-tetramethyl- 5,6,6,7a-tetramethyl-3-phenyl-5,6,7,7a-tetrahydro-pyrazolo[1,5-d][1,2,4]oxadiazole